Benefiting Humanity

Prof. Michael Sela

Copaxone® - MS medication

10.10.2010

Benefiting Humanity, Diagnostic Techniques and Drugs

from the institute to Teva Pharmaceuticals Ltd.

Prof. David Wallach

Anti-Inflammatory Compounds

12.09.2010

Biochemistry, Benefiting Humanity

The proteins identified by Prof. David Wallach are being used in clinical trials as anti-inflammatory compounds that may control rheumatoid...

Prof. Michel Revel

Interleukin-6

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

A drug developed by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.

Prof. Yosef Shaul

Bio-Hep-B vaccine

12.09.2010

Genetics, Benefiting Humanity

Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel

Prof. Yoram Groner

Genetically Engineered Human SOD

12.09.2010

Genetics, Benefiting Humanity

Genetically engineered human SOD, manufactured based on Prof. Yoram Groner's research, is now undergoing clinical trials

Prof. Leo Sachs

Boosting Production of White Blood Cells

12.09.2010

Molecular and Cell Biology, Benefiting Humanity

In the 1960s, Prof. Leo Sachs developed the first ever procedure to grow, clone and induce the development of different types of normal blood cells...

Prof. Leo Sachs

Reversing Malignancy

12.09.2010

Molecular and Cell Biology, Benefiting Humanity

Prof. Leo Sachs was the first to show that cancer cells – in tissue cultures and in living organisms – can be made to revert to normal behavior.

Prof. Emeritus Ephraim Frei

Innovative Imaging System for the Detection of Breast Cancer

12.09.2010

Space & Physics, Benefiting Humanity

Prof. Emeritus Ephraim Frei, a founder of electronics research at the Weizmann Institute in the 1950s, spent several decades studying the effects of...

Prof. Meir Wilchek

Biorecognition

12.09.2010

Biochemistry, Benefiting Humanity

Since the 1960s, Prof. Meir Wilchek has studied "biorecognition”: the process in which biological substances "recognize" one another and form a bond...

Prof. Meir Wilchek

An Immune Cancer Therapy

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

In the late 1980s, Prof. Meir Wilchek developed an immune cancer therapy that employs "T bodies" – white blood T cells engineered...

Pages

Top Stories

A band of clouds above the equator, created by the rise of air within the Hadley cell and responsible for heavy rainfall in this region

Tracking the Winds of Climate Change

Weizmann Institute of Science and Max Planck Society Create a Joint Postdoctoral Program

Mystery Protein Points to New Immune "Smoke Detector"

Prof. Ron Blonder

Prof. Ron Blonder

Press Releases

Weizmann Institute of Science and Max Planck Society Create a Joint Postdoctoral Program

Plant Research Reaches a New High

Decades-Old Mystery of Red Blood Cell Production Finally Solved